FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386035013> ?p ?o ?g. }

• W4386035013 endingPage "123339" @default.
• W4386035013 startingPage "123339" @default.
• W4386035013 abstract "VO(IV) complex is little toxic and highly effective than vanadium salts. A vanadyl metal complex from 8-formyl-7-hydroxy-4-methyl coumarin derivative has been synthesized and functionalized with copper nanoparticles. The Spectrochemical studies such as UV, FTIR, 1NMR and ESR spectra were recorded to characterize the ligand(CUAP), Vanadyl complex[VO(CUAP)SO4] and nano Cu-VO(IV)complex efficiently. The structural studies of vanadyl complex confirmed that the ligand coordinate with metal through nitrogen atom of azomethine, carbonyl oxygen and phenolic oxygen. ESR spectrum of vanadyl complex revealed the covalent nature. XRD pattern of nano Cu-VO(IV) complex indicated the crystalline nature and the average particle size was 20.91 nm. SEM image of nano Cu-VO(IV) complex showed that the nano particles accumulated to form spherical shaped particles. The particle size obtained from Transmission Electron Microscopy of nano functionalized metal complex is ∼ 20 nm. It is closely matched to the particle size calculated from XRD results. Fluorescence of vanadyl complex and nano Cu-VO(IV) complex exhibit the emission from 270 to 900 nm range with significant fluorescence at ∼ 750 nm. The DNA cleavage of all the compounds was evaluated using Agarose gel electrophoresis technique and showed greater cleavage of vanadyl complex. The anticancer activity of compounds was carried out against two cancer cell lines viz Human Breast Cancer Cell line (MCF-7) and Human Leukemia Cancer Cell Line(K-562). Oxovanadium complex exhibited good anticancer activities than ligand and nano-functionalized complex. The antidiabetic activities of vanadyl and nano functionalized complexes were studied against α-Amylase and β-Glucosidase inhibition assay. In this study vanadyl complex showed higher inhibition activity on α-Amylase compared with standard Acarbose. The bioimaging of nano-functionalized metal complex showed high fluorescent properties. The molecular docking study of ligand and vanadyl complex showed greater docking results with CDK2 receptor." @default.
• W4386035013 created "2023-08-22" @default.
• W4386035013 creator A5002262972 @default.
• W4386035013 creator A5006213217 @default.
• W4386035013 creator A5039273897 @default.
• W4386035013 date "2023-09-01" @default.
• W4386035013 modified "2023-10-09" @default.
• W4386035013 title "Development of nanofunctionalized oxovanadium(IV) complex and its anticancer, antidiabetic, DNA cleavage and cell imaging studies" @default.
• W4386035013 cites W1128029328 @default.
• W4386035013 cites W1998722626 @default.
• W4386035013 cites W2005066650 @default.
• W4386035013 cites W2010387887 @default.
• W4386035013 cites W2010419885 @default.
• W4386035013 cites W2010807149 @default.
• W4386035013 cites W2011189185 @default.
• W4386035013 cites W2027542963 @default.
• W4386035013 cites W2038824271 @default.
• W4386035013 cites W2041098719 @default.
• W4386035013 cites W2041317416 @default.
• W4386035013 cites W2043896112 @default.
• W4386035013 cites W2044414253 @default.
• W4386035013 cites W2063450941 @default.
• W4386035013 cites W2070642716 @default.
• W4386035013 cites W2086997985 @default.
• W4386035013 cites W2090969075 @default.
• W4386035013 cites W2109414615 @default.
• W4386035013 cites W2113769442 @default.
• W4386035013 cites W2144807500 @default.
• W4386035013 cites W2168838639 @default.
• W4386035013 cites W2213925009 @default.
• W4386035013 cites W2253619820 @default.
• W4386035013 cites W2264516920 @default.
• W4386035013 cites W2404174027 @default.
• W4386035013 cites W2784332036 @default.
• W4386035013 cites W2886532732 @default.
• W4386035013 cites W2894837458 @default.
• W4386035013 cites W2901142446 @default.
• W4386035013 cites W2909349197 @default.
• W4386035013 cites W2940553791 @default.
• W4386035013 cites W2969375616 @default.
• W4386035013 cites W3036578610 @default.
• W4386035013 cites W3073645904 @default.
• W4386035013 cites W3092426375 @default.
• W4386035013 cites W3104761926 @default.
• W4386035013 cites W3217743171 @default.
• W4386035013 cites W4210479595 @default.
• W4386035013 cites W4360981330 @default.
• W4386035013 doi "https://doi.org/10.1016/j.ijpharm.2023.123339" @default.
• W4386035013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37611853" @default.
• W4386035013 hasPublicationYear "2023" @default.
• W4386035013 type Work @default.
• W4386035013 citedByCount "0" @default.
• W4386035013 crossrefType "journal-article" @default.
• W4386035013 hasAuthorship W4386035013A5002262972 @default.
• W4386035013 hasAuthorship W4386035013A5006213217 @default.
• W4386035013 hasAuthorship W4386035013A5039273897 @default.
• W4386035013 hasConcept C116569031 @default.
• W4386035013 hasConcept C13965031 @default.
• W4386035013 hasConcept C147789679 @default.
• W4386035013 hasConcept C155672457 @default.
• W4386035013 hasConcept C170493617 @default.
• W4386035013 hasConcept C171250308 @default.
• W4386035013 hasConcept C178790620 @default.
• W4386035013 hasConcept C180577832 @default.
• W4386035013 hasConcept C185592680 @default.
• W4386035013 hasConcept C187530423 @default.
• W4386035013 hasConcept C192562407 @default.
• W4386035013 hasConcept C2778271344 @default.
• W4386035013 hasConcept C544153396 @default.
• W4386035013 hasConcept C552990157 @default.
• W4386035013 hasConcept C55493867 @default.
• W4386035013 hasConceptScore W4386035013C116569031 @default.
• W4386035013 hasConceptScore W4386035013C13965031 @default.
• W4386035013 hasConceptScore W4386035013C147789679 @default.
• W4386035013 hasConceptScore W4386035013C155672457 @default.
• W4386035013 hasConceptScore W4386035013C170493617 @default.
• W4386035013 hasConceptScore W4386035013C171250308 @default.
• W4386035013 hasConceptScore W4386035013C178790620 @default.
• W4386035013 hasConceptScore W4386035013C180577832 @default.
• W4386035013 hasConceptScore W4386035013C185592680 @default.
• W4386035013 hasConceptScore W4386035013C187530423 @default.
• W4386035013 hasConceptScore W4386035013C192562407 @default.
• W4386035013 hasConceptScore W4386035013C2778271344 @default.
• W4386035013 hasConceptScore W4386035013C544153396 @default.
• W4386035013 hasConceptScore W4386035013C552990157 @default.
• W4386035013 hasConceptScore W4386035013C55493867 @default.
• W4386035013 hasLocation W43860350131 @default.
• W4386035013 hasLocation W43860350132 @default.
• W4386035013 hasOpenAccess W4386035013 @default.
• W4386035013 hasPrimaryLocation W43860350131 @default.
• W4386035013 hasRelatedWork W1553519660 @default.
• W4386035013 hasRelatedWork W2069486764 @default.
• W4386035013 hasRelatedWork W2073915748 @default.
• W4386035013 hasRelatedWork W2081273895 @default.
• W4386035013 hasRelatedWork W2137761396 @default.
• W4386035013 hasRelatedWork W2307616518 @default.
• W4386035013 hasRelatedWork W2400949416 @default.
• W4386035013 hasRelatedWork W2592612636 @default.

• next